![Axel Dehn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Axel Dehn
Corporate Officer/Principal chez Biopartners GmbH
Profil
Axel Dehn is currently the Head of Pharmacovigilance at Biopartners GmbH since 2007.
He has a graduate degree from Tulane University and a doctorate degree from Hannover Medical School.
Postes actifs de Axel Dehn
Sociétés | Poste | Début |
---|---|---|
Biopartners GmbH
![]() Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Corporate Officer/Principal | 01/01/2007 |
Formation de Axel Dehn
Tulane University (Louisiana) | Graduate Degree |
Hannover Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Biopartners GmbH
![]() Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Health Technology |